Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.

Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.

Item

http://www.wikidata.org/entity/Q36369807

Q36369807

about

Platelets mediate cytotoxic T lymphocyte-induced liver damage.HBV pathogenesis in animal models: recent advances on the role of platelets Immune-mediated Liver Injury in Hepatitis B Virus Infection Mouse models of hepatitis B virus infection comprising host-virus immunologic interactions Hepatitis B: future curative strategies Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis Stealth and cunning: hepatitis B and hepatitis C viruses.Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C The L60V Variation in Hepatitis B Virus Core Protein Elicits New Epitope-Specific Cytotoxic T Lymphocytes and Enhances Viral Replication Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus Immunology of hepatitis B virus and hepatitis C virus infection KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study Different antiviral effects of IFNα subtypes in a mouse model of HBV infection.Genomic analysis of the host response to hepatitis B virus infection.Hepatitis B virus protein X-induced expression of the CXC chemokine IP-10 is mediated through activation of NF-kappaB and increases migration of leukocytes.The Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases.Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infection Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver.Mutations to bid cleavage sites protect hepatocytes from apoptosis after ischemia/reperfusion injury Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infection Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice.Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes Immune control and failure in HCV infection--tipping the balance.Polyfunctional type-1, -2, and -17 CD8⁺ T cell responses to apoptotic self-antigens correlate with the chronic evolution of hepatitis C virus infection.Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes.Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells.Immune response and tolerance during chronic hepatitis B virus infection.Regulation of hepatocyte fate by interferon-γ.CXCL9 associated with sustained virological response in chronic hepatitis B patients receiving peginterferon alfa-2a therapy: a pilot study HCV immunology--death and the maiden T cell.The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function.A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus.Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells.The level of viral antigen presented by hepatocytes influences CD8 T-cell function.Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells Emerging Role of Interleukin 22 in Hepatitis B Virus Infection: a Double-edged Sword.Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.

P2860

Q24604707-96AC0B13-7AD9-4B1F-A921-1A4A04468A16 Q24672103-C2A38C77-BECA-46CF-B9D1-303511C88EEF Q26786772-40158CE8-59B2-4E33-A2F8-6DEB745BF33D Q27002598-3F8843DA-170F-4F91-84A3-B1554E3EAEF8 Q27011623-4BE03A85-18C1-4061-98B6-16B4BE1A4C8D Q27318089-4B3CFD98-215D-4662-9781-1EB115E33F4E Q27349825-59342FF1-5198-4157-857F-4B257882AF56 Q27470232-065A48EC-2E2D-498F-B144-9D0BD7E348AC Q27480302-4923121D-585F-4AF7-9A41-EBF584572AD4 Q27678163-6A48E92B-0452-44CA-82F6-A79CF5E4EC4F Q28221835-51D158E8-5691-4888-B2CB-AD404C16B312 Q29618957-E3E977B3-59BA-4D92-BC8C-956853D26502 Q31037177-40F3D6A6-186C-4C20-AC6E-D2352E78D405 Q33671963-4561C019-1799-4717-B434-D2D226A834B6 Q33696514-D2FD178E-CE88-426C-A4A6-5BD2A6A66C2B Q33782559-E3489296-D319-4C58-9BA0-52FE9AAD6ADF Q33790954-5E4D7E44-9A0A-408A-9ECE-106DB1F3C05E Q33808113-03B62C01-90FA-4C44-B358-3BDEEEB8735E Q33812840-4F81EC11-9099-447F-89F8-D7D3BC19B6B2 Q33855218-4E093EB6-CEDF-45D3-B600-E8F31CD13D11 Q34005464-942CBB35-BB4A-43B6-9BF4-85EAECC672A6 Q34037374-72BA41E5-C634-4163-AB73-D30AFB9316A5 Q34160719-86625C8D-D671-4872-874E-FB3BDCA065C4 Q34178628-CF04F9E9-99F1-4A39-BA39-958E926E70FD Q34318203-865896E4-AB37-4DAA-B17E-CB59389E62F2 Q34465900-D096CF74-06FB-4222-8A7D-B4235F9495F4 Q34586289-9C808C5B-7BDE-4670-8E9D-139E0992B828 Q34627227-50B01605-9E52-4B7A-87B9-92D4BEA9EAAB Q34700332-5A8787A8-EDED-4E17-9CB7-31700614451B Q34748063-E61D7CC9-DF9E-4044-BC9D-5F95B0A6242F Q35017075-966D81B4-CC82-40D9-988F-8AD19F522274 Q35091469-FC70328B-C8B8-4691-A6EC-744832F3D159 Q35108509-BA648BBF-9E27-4944-A70E-32320672B2A0 Q35209368-1243410E-7CA6-45AA-BBCB-838A079C9475 Q35420938-D4DA5386-3A9E-4107-827D-63C2732283A6 Q35690250-938B05B9-5468-4915-8DA5-E9D450D65829 Q35784981-4049F0DD-2C5D-4A44-A4A1-25F860EE0A6F Q35786326-2B71A13D-5DF8-4B0B-AFC3-A13C861397A2 Q35906051-1AA139F3-2A88-4E94-9931-F0C0F8B70FA0 Q35914476-3F7FDB7B-434A-47AF-8B54-7B16BDD48DF0

P2860

Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.

Item

http://www.wikidata.org/entity/Q36369807

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Blocking chemokine responsive ...... cific cytotoxic T lymphocytes.

@ast

Blocking chemokine responsive ...... cific cytotoxic T lymphocytes.

@en

type

Item

label

Blocking chemokine responsive ...... cific cytotoxic T lymphocytes.

@ast

Blocking chemokine responsive ...... cific cytotoxic T lymphocytes.

@en

prefLabel

Blocking chemokine responsive ...... cific cytotoxic T lymphocytes.

@ast

Blocking chemokine responsive ...... cific cytotoxic T lymphocytes.

@en

P1476

Blocking chemokine responsive ...... ecific cytotoxic T lymphocytes

@en

P2093

I L Campbell

http://www.w3.org/2001/XMLSchema#string

K Kakimi

http://www.w3.org/2001/XMLSchema#string

S Wieland

http://www.w3.org/2001/XMLSchema#string

T E Lane

http://www.w3.org/2001/XMLSchema#string

V C Asensio

http://www.w3.org/2001/XMLSchema#string

P2860

Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver

Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays

Chemokines: a new classification system and their role in immunity

The biology of chemokines and their receptors

Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection.

Cytotoxic T lymphocytes, chemokines and antiviral immunity.

The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo.

Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.

Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression?

Hepatitis B virus biology.

P304

1755-1766

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.194.12.1755

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

194

http://www.w3.org/2001/XMLSchema#string

P50

Francis V. Chisari

Luca G. Guidotti

P577

2001-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274167990

http://www.w3.org/2001/XMLSchema#string

P698

11748277

http://www.w3.org/2001/XMLSchema#string

P921

cytotoxicity

pathogenesis

lymphocyte

P932

2193580

http://www.w3.org/2001/XMLSchema#string

Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.

about

P2860

P2860

Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932